CVS Health Stock Climbs 12% On A 5-Day Winning Streak
CVS Health (CVS) stock is on a 5-day winning streak, up 12.0% since the run began. That added about $12.3 billion to the company’s market value, which now stands at about $114.8 billion. The stock closed at $89.52 on Wednesday, November 11, 18.0% below its 52-week high of $109.14 and 30.6% above its low of $68.55.
The Streak Next To The S&P 500
Returns for CVS and the S&P 500 over the streak and the periods around it, all ending Wednesday, November 11 and including dividends:
| Return Period | CVS | S&P 500 |
|---|---|---|
| 1 Day | 0.6% | 1.3% |
| 5 Days (Current Streak) | 12.0% | -0.9% |
| 1 Month (21 Trading Days) | 3.0% | -2.3% |
| 3 Months (63 Trading Days) | -5.1% | -2.0% |
| Year To Date | 16.3% | 12.4% |
| 1 Year (252 Trading Days) | 19.0% | 12.8% |
Is This Move About CVS Health Or The Market?
The market explains little of this: the S&P 500 lost 0.9% over the same 5 sessions, including dividends, against CVS Health’s +12.0%. 4 other S&P 500 stocks are currently on winning streaks of 5 days or longer. Over the past three months the stock is down 5.1%, a window that includes the streak; over the other 58 sessions of that window it was down 15.2%.
What The Numbers Say About The Rally
On the fundamentals, revenue grew 6.7% over the last twelve months, against a median of 7.9% for S&P 500 Health Care stocks; its operating margin is 3.6%, versus a median of 17.4%; and the stock trades at 10.4 times trailing earnings against a median of 31.4. The read is mixed: a multiple below the median on one side, revenue growth below the median and margins below the median on the other.
If you are looking for strength with more behind it than a hot tape, our Guidance Momentum screen surfaces the names where management raised its own outlook.
Prefer the theme to the single name? A U.S. healthcare providers ETF like IHF holds the whole group, not just this stock. It is still a concentrated bet on one theme, which is the gap the portfolio below is built to close.
Momentum Is A Tailwind, Not A Plan
Riding a stock that rises every day feels effortless, and that is precisely the danger: the same momentum that built this run can reverse without notice, and one name’s reversal should never be able to reset your whole year.
That is what the Trefis High Quality (HQ) Portfolio is for: about 30 quality businesses screened for the fundamentals that survive momentum’s mood swings, held with rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Watch the runs; own the resilience.